American Vanguard Corporation ( AVD ) Q3 2025 Earnings Call November 10, 2025 9:00 AM EST Company Participants Anthony Young - Director of Investor Relations Douglas Kaye - Chairman & CEO David Johnson - Chief Financial Officer Conference Call Participants Michael Harrison - Seaport Research Partners Wayne Pinsent - The Gabelli Healthcare & Wellness Trust Charles Rose Dmitry Silversteyn - Water Tower Research LLC Presentation Operator Greetings, and welcome to the American Vanguard Third Quarter 2025 Earnings Conference Call. [Operator Instructions] And please note, this conference is being recorded.
2Q25 results show early signs of operational turnaround, with improved margins and lower OpEx, supporting my ongoing Buy rating for American Vanguard. Management sees the destocking cycle nearing its end, setting up for revenue and margin gains in 2H25 as inventory levels normalize. Operational leverage is materializing: modest revenue growth drove significant profitability gains, highlighting AVD's earnings potential even in a weak crop price environment.
AVD offers differentiated, branded agrochemicals with global distribution, but lacks patent protection and faces cyclical demand tied to corn prices. Recent operational challenges, including a major product recall and impairments, led to significant one-time losses, but normalized margins could yield $15–21 million in net income. Despite financial and regulatory risks, AVD's secular 5-6% growth and current valuation suggest a 15% potential yield, making shares attractive for a small position.
| Chemicals Industry | Materials Sector | Douglas A. Kaye CEO | CXA Exchange | US0303711081 ISIN |
| US Country | 845 Employees | 10 Jul 2024 Last Dividend | 18 Apr 2006 Last Split | - IPO Date |
American Vanguard Corporation, rooted in its operation since 1969, stands as a significant player in the chemical manufacturing industry, with a focus on serving the agricultural sector, alongside commercial and consumer markets both in the United States and globally. With its headquarters in Newport Beach, California, the company is engaged in the development, manufacture, and marketing of specialized chemicals that are instrumental in addressing a wide range of needs. From farming to consumer health protection, American Vanguard’s operations span across a multifaceted spectrum, ensuring a comprehensive approach towards chemical solutions.